KRAS

Researchers find genes behind aggressive ovarian and endometrial carcinosarcomas.

In a major breakthrough for ovarian and uterine cancers, Yale researchers have defined the genetic landscape of rare, highly aggressive tumors called carcinosarcomas (CSs), pointing the way to possible new treatments. The findings are published in the Oct. 10 online early edition of Proceedings of the National Academy of Sciences. Panel showing both epithelial and …

Researchers find genes behind aggressive ovarian and endometrial carcinosarcomas. Read More »

Genetic targets in Colorectal Cancer: role of KRAS, MEK and TAK1 genes Identified.

Researchers from Boston University School of Medicine have discovered a possible strategy to treat colon cancers that are caused by the mutant KRAS gene, which is responsible for approximately half of all colon cancer cases. The findings, which appear online in the journal Molecular Cancer Research, may lead to better therapeutic agents to treat this …

Genetic targets in Colorectal Cancer: role of KRAS, MEK and TAK1 genes Identified. Read More »